Speed up the ECG screening process with KardiaStation

Prescribing and managing QT-prolonging medications just got easier

CONTACT US

Speed up the ECG screening process with KardiaStation

Prescribing and managing QT-prolonging medications just got easier

CONTACT US

THE PROBLEM

Many commonly prescribed 
medications cause QT prolongation

A prolonged QT interval may lead to a dangerously fast rhythm, Torsades de Pointe, which is a potentially fatal polymorphic ventricular tachycardia (VT).

To assess the risk associated with long QT, the FDA requires a baseline ECG when prescribing or titrating some QT-prolonging medications. This requirement may present a barrier to physicians and patients to be able to start treatment without delay.

The most frequent therapeutic categories with QT prolongation issues include antiarrhythmics, antipsychotics, 47.9% of outpatient psychiatry patients were at risk for QT prolongation due to a drug-drug interaction (DDI) in a study of 1,326 participants in India¹

Increasing likelihood of >1 QT prolonging medications due to more medically complex patients or modifiable (eg, electrolyte abnormalities) and non-modifiable (eg, diabetes, age, gender) QTc aggravating risk factors³

10-100x higher rate of TdP reported by active surveillance systems (vs. spontaneous reports)⁷𝄒⁴

8x increase in risk of sudden cardiac death for patients >65 years⁷

THE PROBLEM

Many commonly prescribed 
medications cause QT prolongation

A prolonged QT interval may lead to a dangerously fast rhythm, Torsades de Pointe, which is a potentially fatal polymorphic ventricular tachycardia (VT).

To assess the risk associated with long QT, the FDA requires a baseline ECG when prescribing or titrating some QT-prolonging medications. This requirement may present a barrier to physicians and patients to be able to start treatment without delay.

The most frequent therapeutic categories with QT prolongation issues include antiarrhythmics, antipsychotics, 47.9% of outpatient psychiatry patients were at risk for QT prolongation due to a drug-drug interaction (DDI) in a study of 1,326 participants in India¹

Increasing likelihood of >1 QT prolonging medications due to more medically complex patients or modifiable (eg, electrolyte abnormalities) and non-modifiable (eg, diabetes, age, gender) QTc aggravating risk factors³

10-100x higher rate of TdP reported by active surveillance systems (vs. spontaneous reports)⁷𝄒⁴

8x increase in risk of sudden cardiac death for patients >65 years⁷

“There is no absolute QTc interval at which a psychotropic should not be used, rather a comprehensive risk-benefit analysis should include an assessment of pharmacologic and non-pharmacologic risks for TdP versus the risk of failure to control high-risk psychopathology or of psychiatric decompensation.”

AMERICAN PSYCHIATRIC ASSOCIATION (APA) RESOURCE DOCUMENT ON QTC PROLONGATION & PSYCHOTROPIC MEDICATIONS (2018)

Practice Impacts

  • Improve outcomes with a proactive condition management program
  • Reduce cost by optimizing healthcare utilization through prevention and clinical management
  • Augment existing health programs and care

Patient Impacts

  • Inconvenience of extra visit for ECG
  • Potential for additional costs
  • Possible lack of follow-up
  • May miss out on optimal care

Practice Impacts

  • Improve outcomes with a proactive condition management program
  • Reduce cost by optimizing healthcare utilization through prevention and clinical management
  • Augment existing health programs and care

Patient Impacts

  • Inconvenience of extra visit for ECG
  • Potential for additional costs
  • Possible lack of follow-up
  • May miss out on optimal care

THE SOLUTION

KardiaStation can dramatically
simplify the process
of prescribing QT-prolonging medications

KardiaStation delivers a robust solution to the problem of prescribing medications that are known to cause QT prolongation.

The service is comprised of three integrated technologies that seamlessly work together to provide you with a faster, easier process for performing an ECG in-office before prescribing or titrating these medications.

KardiaMobile® 6L

#1 doctor-recommended personal ECG brand

KardiaStation App

Connects with KardiaMobile 6L for accurate QT readings

KardiaPro® Portal

Track, manage and document patient results

THE SOLUTION

KardiaStation can dramatically
simplify the process
of prescribing QT-prolonging medications

KardiaStation delivers a robust solution to the problem of prescribing medications that are known to cause QT prolongation.

The service is comprised of three integrated technologies that seamlessly work together to provide you with a faster, easier process for performing an ECG in-office before prescribing or titrating these medications.

KardiaMobile® 6L

#1 doctor-recommended personal ECG brand

KardiaStation App

Connects with KardiaMobile 6L for accurate QT readings

KardiaPro® Portal

Track, manage and document patient results

Record ECGs in 30 Seconds

The easy-to-use, FDA-cleared KardiaMobile 6L device allows you to quickly capture an ECG.

Validated QT Measurements

Leveraging advanced FDA-cleared algorithm to inform your treatment selection.

Easy Workflow Integration

Data is securely stored and fits into existing practice workflow through KardiaPro web-based portal or integration options with EHR, SDK, or API

Record ECGs in 30 Seconds

The easy-to-use, FDA-cleared KardiaMobile 6L device allows you to quickly capture an ECG.

Validated QT Measurements

Leveraging advanced FDA-cleared algorithm to inform your treatment selection.

Easy Workflow Integration

Data is securely stored and fits into existing practice workflow through KardiaPro web-based portal or integration options with EHR, SDK, or API

TRUSTED RESULTS

Results that help you prescribe with confidence

KardiaStation delivers a streamlined way to screen for QT prolongation that is grounded in proven results.

The six leads of KardiaMobile 6L are equivalent to the same six leads from a gold standard 12-lead ECG⁵

KardiaMobile 6L is able to detect Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with SVE, Sinus Rhythm with PVCs and Sinus Rhythm with Wide QRS†

Kardia personal ECG devices are used by the world’s leading cardiologists

TRUSTED RESULTS

Results that help you prescribe with confidence

KardiaStation delivers a streamlined way to screen for QT prolongation that is grounded in proven results.

The six leads of KardiaMobile 6L are equivalent to the same six leads from a gold standard 12-lead ECG⁵

KardiaMobile 6L is able to detect Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with SVE, Sinus Rhythm with PVCs and Sinus Rhythm with Wide QRS†

Kardia personal ECG devices are used by the world’s leading cardiologists

Accurate QT Measurements

  • Instantly displays accurate QT interval measurements

Faster Screening

  • Capture a medical-grade ECG in just 30 seconds
  • Easily integrated into existing visit
  • FDA-cleared determinations of the 6 most common arrhythmias
  •  

Easier ECG Process

  • No patient prep time or adhesives are needed

  • Instant, actionable data to help you make faster clinical decisions

Accurate QT Measurements

  • Instantly displays accurate QT interval measurements

Faster Screening

  • Capture a medical-grade ECG in just 30 seconds
  • Easily integrated into existing visit
  • FDA-cleared determinations of the 6 most common arrhythmias
  •  

Easier ECG Process

  • No patient prep time or adhesives are needed

  • Instant, actionable data to help you make faster clinical decisions

The KardiaStation Solution

The KardiaStation Solution

 

Get started with KardiaStation.

With AliveCor’s portfolio of flexible subscription plans, incorporating KardiaStation into your practice is easy.

 

Get started with KardiaStation.

With AliveCor’s portfolio of flexible subscription plans, incorporating KardiaStation into your practice is easy.

CONTACT US

 

Legal & Referencess

* AliveCor makes no guarantee, promise, or direct instruction regarding billing, coverage, or reimbursement. Accurate coding and claims submission practices are the sole responsibility of the health care provider.† KardiaMobile 6L does not check for heart attack.

  1. Woosley RL, Heise CW, Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, September 13, 2023.
  2. Das B, et al. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medication sand related drug-drug interactions in a cohort of psychiatry patients. Therapies (2019).
  3. Swenson RS, et al. Prolonged QT Interval in Patients Receiving Psychotropic Medications. Journal of the American Psychiatric Nurses Association. 2020;26(4):344-353.
  4. Funk MC, et al. Resource Document on GTc Prolongation and Psychotropic Medications. American Psychiatric Association (APA) Reference Document. Approved June 2018.
  5. Azram M, et al., Clinical validation and evaluation of a novel six-lead handheld electrocardiogram recorder compared to the 12-lead electrocardiogram in unselected cardiology patients (EVALECG Cardio), European Heart Journal — Digital Health, Volume 2, Issue 4, December 2021.
  6. Hnatkova K, et al. Precision of QT interval measurement by advanced electrocardiographic equipment. Pacing Clin Electrophysiol. 2096;29(11): 1277-84.

Contact Us

Don't hesitate to contact us via email or phone to learn more.

Email: enquiry@mellica.com
Phone: +852 34695611

Contact Us

Don't hesitate to contact us via email or phone to learn more.

Email: enquiry@mellica.com
Phone: +852 34695611